[Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Red blood cell filtration, platelet aggregation, serum triglyceride and cholesterol levels were investigated in 15 patients with chronic cerebrovascular disease, 10 of whom treated with Suloctidil and 5 with pentoxifylline. The treatment was carried out in 90 days. Both pentoxifylline and Suloctidil produced a significant improvement of erythrocyte deformability and a decrease of platelet aggregation.
D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D004912:Erythrocytes / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D010431:Pentoxifylline / Q000627:therapeutic use*; D010974:Platelet Aggregation / Q000187:drug effects; D011412:Propanolamines / Q000627:therapeutic use*; D013468:Suloctidil / Q000627:therapeutic use*; D013805:Theobromine / Q000031:analogs & derivatives*; D014280:Triglycerides / Q000097:blood
D011412:Propanolamines; D014280:Triglycerides; D002784:Cholesterol; D013805:Theobromine; D010431:Pentoxifylline; D013468:Suloctidil
L'insufficienza cerebrovascolare cronica senile. Effetti del suloctidil e della pentossifillina sulla deformabilità eritrocitaria.